Drug Makers Promise To Help Curb Antibiotic Overuse At UN Special Meeting

Amid increasing concerns worldwide about the overuse of antibiotics, and the potential long-term health consequences, the United Nations held a rare Special Meeting this week to discuss and explore solutions to the spread of antibiotic resistant diseases caused by overuse of the medications. 

The U.N. special meeting was held Wednesday, as part of the United Nations General Assembly in New York, defining the worsening antibiotic resistance problem as a global issue, instead of one that only affects the developed world.

Many infections that were once treated with antibiotics are now resistant to those same drugs. Researchers estimate nearly 700,000 people around the world die from drug-resistant bacteria every year. A 2014 British report warned that antibiotic resistant bacteria will cause more than 10 million deaths globally every year by the year 2050, unless drastic measures are taken to mitigate the growing problem.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The UN meeting focused on ways to curb the use of antibiotics, especially in unnecessary settings, as well as called for countries to focus on development of new medicines.

Through an acclamation, member states agreed to a number of actions in a draft political declaration. The declaration calls for the mobilization of resources in a concerted “One Health” approach that tries to connect all the various sectors and health factors that can contribute to antibiotic resistance and see the problem as one whole picture.

The declaration states that resistance to antibiotics and other antimicrobial drugs comes primarily due to the inappropriate use of such drugs in public health, livestock and agriculture. The declaration calls on the World Health Organization and other health agencies to develop a plan on worldwide antimicrobial use.

The declaration must be agreed upon by the General Assembly.

“We are losing our ability to protect both humans and animals from life-threatening infections,” U.N. Secretary-General Ban Ki-Moon said in his opening remarks. “If we fail to address this problem quickly and comprehensively, antimicrobial resistance will make providing high-quality, universal health coverage more difficult, if not impossible.”

This is only the fourth time the U.N. has held a special session on health issues. Previous sessions included a 2001 session on the AIDS virus, a 2011 session on non-communicable disease, and the 2014 session on Ebola.

Drugmakers Also Seek To Curb Antibiotic Overuse

The UN meeting came a day after a special meeting held Tuesday involving 13 prominent drug manufacturers. The group of pharmaceutical companies agreed to take steps to stop the overuse of antibiotics and medications used to treat drug resistant bacteria. The drug makers also promised to clean up pollution created by their antibiotics factories.

Companies involved with the meeting and promising cooperation included Pfizer, Merck, Novartis, GlaxoSmithKline, Allergan, Cipla and Wockhardt.

Independent drug experts will work with the group to set new factory standards to ensure antibiotic manufacturing waste does not enter the country’s waterways, which not only pollutes the nation’s water, but contributes to the emergence of antibiotic resistant superbugs.

The companies also laid out a plan to review their promotional activities and to put in place measures by 2020 to remove incentives designed to sell antibiotics in large volumes.

Image Credit: Image via BarryTuck / Shutterstock.com


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted yesterday)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted 2 days ago)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.